Abstract:Objective To identify specific differentially expressed proteins (DEPs) in the nasal mucosa of patients with secondary atrophic rhinitis and explore the protein-level molecular mechanism of the occurrence and progression of this disease. Methods The protein expression profiles of nasal mucosa tissues from patients with secondary atrophic rhinitis and normal nasal mucosa tissues from patients with maxillary sinus cysts were quantitatively analyzed. DEPs were identified based on fold change (FC) >1.2 or<0.83 and P<0.05, followed by gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses. Results A total of 291 DEPs were identified, including 53 upregulated proteins and 238 downregulated ones. GO enrichment analysis revealed that DEPs were mainly involved in processes such as endoplasmic reticulum-Golgi vesicle transport, structural components of ribosomes, and cytoplasmic large ribosomal subunits. KEGG enrichment analysis showed that DEPs were primarily involved in pathways related to sphingolipid biosynthesis, protein transport and processing. Conclusions Using 4D-label-free technology, specific DEPs are identified in the nasal mucosa of patients with secondary atrophic rhinitis. Proteins with significant differential expression, such as COL6A6, MPP1, GOLGA4, and SLC38A10, may play critical roles in the pathogenesis and progression of secondary atrophic rhinitis.